N-(3-bromophenyl)-1H-imidazo[4,5-g]quinazolin-8-amine

ADVERTISEMENT

Identification

Molecular formula
C16H11BrN6
CAS Number
257878-97-4
IUPAC Name
N-(3-bromophenyl)-1H-imidazo[4,5-g]quinazolin-8-amine
Molecular Weight
344.20g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.7900g/cm3
Synonyms
N-(3-bromophenyl)-1H-imidazo[4, 5-g]quinazolin-8-amine
Interesting facts

Interesting Facts About N-(3-bromophenyl)-1H-imidazo[4,5-g]quinazolin-8-amine

N-(3-bromophenyl)-1H-imidazo[4,5-g]quinazolin-8-amine is a fascinating compound that stands out due to its unique structure and potential applications in various fields. Here are some intriguing aspects:

  • Pharmaceutical Potential: Compounds with imidazoquinazolines have garnered attention within the pharmaceutical industry, particularly for their roles as potential therapeutics against cancer and infectious diseases.
  • Tailored Properties: The presence of the bromine atom enhances the compound's reactivity and may help in modifying its pharmacokinetic properties, making it an interesting candidate for drug development.
  • Structure Complexity: This compound features a complex heterocyclic structure that combines both imidazole and quinazoline rings, offering insights into the rich chemistry of nitrogen-containing heterocycles.
  • Research Interest: Studies focusing on this type of compound often explore mechanisms of action at the molecular level, which can lead to the discovery of new drugs targeting specific biological pathways.
  • Comparative Studies: Researchers frequently compare the effectiveness of imidazoquinazolines with other compounds to evaluate their medicinal benefits, enhancing our understanding of structure-activity relationships.

In conclusion, N-(3-bromophenyl)-1H-imidazo[4,5-g]quinazolin-8-amine serves as an excellent representative of the intricate and diverse world of synthetic organic compounds. Its unique features make it a subject of ongoing research and a promising candidate for future pharmaceutical advancements.

ADVERTISEMENT